Plus: ANZ boss Matos focused on transformation, not online backlash; US regulator call tipped Pfizer’s USD10b Metsera win: Bloomberg; Trump threatens USD1b lawsuit over BBC’s Panorama edit.

AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side ...

The S&P 500 Index ($SPX) (SPY) today is down -0.97%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.69%, and the ...

The president and top health officials acknowledged using the leverage of tariff threats to forge an agreement. Other companies are still in negotiations with the White House. By Rebecca Robbins and ...

Pfizer is one of the largest pharmaceutical companies on the planet. It has a proven track record of finding, developing, and commercializing new drugs. The recent price advance is worth paying ...

WASHINGTON — President Donald Trump and drug manufacturer Pfizer announced a deal Tuesday to lower certain drug prices. The arrangement would bring American drug prices in line with the lowest paid by ...

Listen to more stories on the Noa app. Sign up for Trump’s Return, a newsletter featuring coverage of the second Trump presidency. Donald Trump, always one to tout his knack for dealmaking, declared ...

--Best four day stretch since the four days ending Dec. 16, 2021, when it rose 16.05% --Up 2.62% year-to-date; on pace for best year since 2021, when it rose 60.42% --Down 55.55% from its all-time ...

Pfizer shares jumped 6.83% Tuesday after President Trump said the drugmaker would offer some of its drugs on a new direct-to-consumer website and would introduce new drugs to the U.S. market at ...

President Donald Trump today, Sept. 30, announced TrumpRX, a new website for Americans to buy drugs, while he touted lower prices across Pfizer drugs, according to the Wall Street Journal. Trump ...

Pfizer is facing a landmark lawsuit in the US brought on behalf of more than 1,000 women who say they developed brain tumors after taking the popular contraceptive injection Depo-Provera. On Monday, ...

Pfizer Inc. secured a reprieve from President Donald Trump’s long-threatened tariffs on the pharmaceutical industry Tuesday by agreeing to slash some of its drug prices by up to 85% and selling ...